MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Tabula Rasa HealthCare Book Value 2011-2026 | TRHC
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Tabula Rasa HealthCare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -57 M | 55.8 M | 169 M | 186 M | 139 M | 122 M | 56.1 M | -31.6 M | -20 M | -16 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | -57 M | 60.3 M |
Quarterly Book Value Tabula Rasa HealthCare
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -78.1 M | -70.9 M | -57 M | -31.7 M | - | 36.2 M | 55.8 M | 67.2 M | 75.8 M | 83.6 M | 169 M | 169 M | 169 M | 169 M | 186 M | 186 M | 186 M | 186 M | 139 M | 139 M | 139 M | 139 M | 124 M | 124 M | 124 M | 124 M | 56.1 M | 56.1 M | 56.1 M | 56.1 M | -2.66 M | -2.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | -78.1 M | 89.3 M |
Book Value of other stocks in the Health information services industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
3.68 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
187 M | - | 4.4 % | $ 133 M | USA |
 |
Change Healthcare
CHNG
|
3.28 B | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
391 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
7.25 B | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
715 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
26.4 M | - | - | $ 6.37 B | USA |
 |
Covetrus
CVET
|
1.53 B | - | - | $ 2.94 B | USA |
 |
HealthStream
HSTM
|
511 M | $ 19.88 | -1.39 % | $ 604 M | USA |
 |
Evolent Health
EVH
|
859 M | $ 2.64 | -1.12 % | $ 247 M | USA |
 |
Health Catalyst
HCAT
|
365 M | $ 1.84 | -7.54 % | $ 111 M | USA |
 |
iCAD
ICAD
|
28.7 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-7.01 M | - | - | $ 161 M | USA |
 |
Progyny
PGNY
|
422 M | $ 20.98 | -2.65 % | $ 1.8 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.41 B | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
2.04 B | $ 73.21 | -4.82 % | $ 6.26 B | USA |
 |
American Well Corporation
AMWL
|
248 M | $ 4.33 | - | $ 69.5 M | USA |
 |
MTBC
MTBC
|
49.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
1.96 B | $ 3.45 | -6.76 % | $ 274 M |  China |
 |
10x Genomics
TXG
|
741 M | $ 17.51 | - | $ 2.05 B | USA |
 |
GoodRx Holdings
GDRX
|
725 M | $ 2.18 | - | $ 841 M | USA |
 |
Omnicell
OMCL
|
1.24 B | $ 36.18 | -4.34 % | $ 1.67 B | USA |
 |
OptimizeRx Corporation
OPRX
|
127 M | $ 8.21 | -11.05 % | $ 141 M | USA |
 |
1Life Healthcare
ONEM
|
1.73 B | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
1.53 B | - | - | $ 2.33 B | USA |
 |
Phreesia
PHR
|
251 M | $ 11.86 | - | $ 647 M | USA |
 |
Zhongchao
ZCMD
|
24.2 M | $ 0.23 | -7.19 % | $ 1.2 M | China |
 |
R1 RCM
RCM
|
347 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-225 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
432 M | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
421 M | $ 11.31 | - | $ 822 M | USA |
 |
Signify Health
SGFY
|
821 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
12.3 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
1.49 B | $ 4.47 | - | $ 762 M | USA |
 |
Veeva Systems
VEEV
|
4.64 B | $ 171.99 | -2.85 % | $ 27.6 B | USA |
 |
SCWorx Corp.
WORX
|
4.49 M | $ 0.25 | - | $ 365 K | USA |